Showing results (701-710 of 3,150) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|May 9, 2024
SMYD2 induced PGC1α methylation promotes stemness maintenance of glioblastoma stem cellsMengdie Li, Zhixiang Zhang, Liuguijie He, et al.Neuro-Oncology|May 8, 2024
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profileGunther Nussbaumer, Martin Benesch, Yura Grabovska, et al.Neuro-Oncology|May 6, 2024
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020Mackenzie Price, Corey Neff, Nitin Nagarajan, et al.Neuro-Oncology|May 21, 2024
Consensus review on strategies to improve delivery across the blood-brain barrier including focused ultrasoundKeaton Piper, Jay I Kumar, Joseph Domino, et al.Neuro-Oncology|May 21, 2024
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncologyRifaquat Rahman, Diana D Shi, Zachary J Reitman, et al.Neuro-Oncology|January 13, 2026
ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: a single-arm, phase 1/2 studyWei Zeng, Peiwen Wang, Sheng Fang, et al.Neuro-Oncology|January 15, 2026
KMT2A is a prerequisite of malignant transformation during IDH-mutant gliomagenesisMarilin S Koch, Minh Deo, Claudia Schmidt, et al.Neuro-Oncology|January 31, 2026
A brief history of ependymomaDavid R Ghasemi, Denise Obrecht-Sturm, Kimberly M Wallgren, et al.Neuro-Oncology|January 31, 2026
Distinct tumor immune microenvironmental (TIME) landscapes drive divergent immunotherapy responses in glioblastomaLinqian Weng, Krish Skandha Gopalan, Mélanie Guyot, et al.Neuro-Oncology|February 3, 2026
Meningioma microenvironment harbors a rich immune landscape that evolves with biological stateXiaopeng Guo, Zachary A Moynihan, Joseph Driver, et al.Pageof 315